Evidence map›Paper›PMID 41732382›Full record

ArticleMaterials today. Bio2026

Ultra-thin elastin-based membranes as an innovative dressing to enhance skin wound healing.

D Juanes-Gusano, M Puertas-Bartolomé, L Mbundi, X Bian, J Geara, N Xu Landén, P Cidad, M Santos, J C Rodríguez-Cabello, M Alonso

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Advancements in Functional Polymeric Scaffolds for Scar-Free Skin Regeneration.Polymer science & technology (Washington, D.C.) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

D Juanes-GusanoBIOFORGE (Group for Advanced Materials and Nanobiotechnology), University of Valladolid- CIBER BBN-LADIS, Edificio Lucía, Paseo de Belén 19, Valladolid, 47011, Spain.
M Puertas-BartoloméBIOFORGE (Group for Advanced Materials and Nanobiotechnology), University of Valladolid- CIBER BBN-LADIS, Edificio Lucía, Paseo de Belén 19, Valladolid, 47011, Spain.
L MbundiBIOFORGE (Group for Advanced Materials and Nanobiotechnology), University of Valladolid- CIBER BBN-LADIS, Edificio Lucía, Paseo de Belén 19, Valladolid, 47011, Spain.
X BianDermatology and Venereology Division, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, 17176, Sweden.
J GearaDermatology and Venereology Division, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, 17176, Sweden.
N Xu LandénDermatology and Venereology Division, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, 17176, Sweden.
P CidadDepartment of Biochemistry and Molecular Biology and Physiology, Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM), University of Valladolid, Valladolid, Spain.
M SantosBIOFORGE (Group for Advanced Materials and Nanobiotechnology), University of Valladolid- CIBER BBN-LADIS, Edificio Lucía, Paseo de Belén 19, Valladolid, 47011, Spain.
J C Rodríguez-CabelloBIOFORGE (Group for Advanced Materials and Nanobiotechnology), University of Valladolid- CIBER BBN-LADIS, Edificio Lucía, Paseo de Belén 19, Valladolid, 47011, Spain.
M AlonsoBIOFORGE (Group for Advanced Materials and Nanobiotechnology), University of Valladolid- CIBER BBN-LADIS, Edificio Lucía, Paseo de Belén 19, Valladolid, 47011, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of advanced wound dressings that combine mechanical compliance, bioactivity, and controlled biodegradability remains an unmet need in skin regeneration, particularly for chronic and complex wounds where cell-cell and cell-extracellular matrix (ECM) interactions are severely disrupted. Here, we report the development of ultra-thin, highly compliant elastin-like recombinamer (ELR) membranes designed as ECM-mimetic wound dressings that actively support tissue regeneration. The membranes are fabricated via a catalyst-free click-chemistry reaction at a liquid-liquid interface, enabling tuneable thickness (5-25 μm), surface topography, wettability, and enzymatic degradability.

Indexed as

BiocompatibilityElastin-like recombinamers (ELR)Scaffold materialsTissue regenerationWound healing

Identifiers

PMID41732382
PMCPMC12925300

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.